LoginGet started
Picture of China Shineway Pharmaceutical logo

2877 — China Shineway Pharmaceutical Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual cashflow statement for China Shineway Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line6433957209171,240
Depreciation
Amortisation
Non-Cash Items-85.3116-98-126-120
Unusual Items
Other Non-Cash Items
Changes in Working Capital-394-81.1-101133-365
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities3686397031,110933
Capital Expenditures-91.4-66-93.6-129-144
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items161-2404898494.8
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities69.5-306395-45.4-49.5
Financing Cash Flow Items-246-54.61.17-0.63-2.6
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-101-330-829-250-26.7
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash335-3263821863